OneSource Specialty Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 481.32 | 342.66 | 249.65 |
| Operating Expense | 241.15 | 337.79 | 229.99 |
| Net Profit | 174.19 | -73.02 | -57.89 |
| Net Profit Margin | 36.19 | -21.31 | -23.19 |
| Earning Per Share | 15.22 | -6.69 | -13.93 |
| EBIDTA | 240.17 | 4.88 | 19.66 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 481.32 |
| Operating Expense | 241.15 |
| Net Profit | 174.19 |
| Net Profit Margin | 36.19 |
| Earning Per Share | 15.22 |
| EBIDTA | 240.17 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 171.92 | 38.71 | 132.13 |
| Operating Expenses Annual | 259.44 | 199.33 | 229.36 |
| Operating Profit Annual | -224.69 | -685.89 | -91.37 |
| Interest Annual | 89.42 | 47.55 | 68.02 |
| Depreciation | 81.31 | 109.92 | 69.43 |
| Net Profit Annual | -364.93 | -429.55 | -229.74 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 171.92 |
| Operating Expenses Annual | 259.44 |
| Operating Profit Annual | -224.69 |
| Interest Annual | 89.42 |
| Depreciation | 81.31 |
| Net Profit Annual | -364.93 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 9.41 | 121.47 | 66.92 |
| Cash Flow from Operations | -108.99 | -164.70 | -419.66 |
| Cash Flow from Investing | 505.99 | -65.68 | -684.54 |
| Cash Flow from Financing | -384.22 | 118.32 | 1,158.75 |
| Cash Flow at the End | 22.19 | 9.41 | 121.47 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 9.41 |
| Cash Flow from Operations | -108.99 |
| Cash Flow from Investing | 505.99 |
| Cash Flow from Financing | -384.22 |
| Cash Flow at the End | 22.19 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -45.51 | -298.97 | -69.15 |
| PBIT Margin (%) | -89.88 | -580.24 | -122.39 |
| PBT Margin (%) | -88.87 | -568.05 | -120.59 |
| Net PROFIT Margin (%) | -227.08 | -2,064.35 | -173.87 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -29.52 | -41.29 | -13.91 |
| Total Debt / Equity (X) | 1.21 | 1.12 | 0.86 |
| Asset Turnover Ratio (%) | 0.13 | 0.02 | 0.08 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -45.51 |
| PBIT Margin (%) | -89.88 |
| PBT Margin (%) | -88.87 |
| Net PROFIT Margin (%) | -227.08 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -29.52 |
| Total Debt / Equity (X) | 1.21 |
| Asset Turnover Ratio (%) | 0.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 1,007.88 | 1,504.57 | 1,603.10 |
| Total Current Assets Annual | 176.42 | 228.21 | 511.67 |
| Non Current Assets Annual | 1,132.16 | 1,780.23 | 1,933.33 |
| Total Shareholders Funds Annual | 397.74 | 786.71 | 1,015.51 |
| Total Assets Annual | 1,308.58 | 2,008.44 | 2,445.00 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 1,007.88 |
| Total Current Assets Annual | 176.42 |
| Non Current Assets Annual | 1,132.16 |
| Total Shareholders Funds Annual | 397.74 |
| Total Assets Annual | 1,308.58 |
EPS (INR)
Expected
8.61
Reported
8.61
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
